Default company panoramic image
F496bf79 0c6c 49d4 baef 8e4173688a92

Trinity Laboratories, Inc

Trinity Laboratories, Inc. is dedicated to bringing safer and more effective pharmaceuticals to market through innovative drug development.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location San Antonio, TX, USA
  • Currency USD
  • Employees 5
  • Website

Company Summary

Trinity Laboratories, Inc. is a research and development biotechnology company engaged in the development of pharmaceuticals for the treatment of human disease. Our products and intellectual portfolio consist of OTC and prescription products to treat cancer, pain, premature ejaculation, cold sores and herpes simplex among others. Our products are designed to be safer and more effective than current treatments.


  • Default avatar
    James Walter Simmons, D.O, Ph.D., MBA

    A practicing spine surgeon, business entrepreneur and research scientist. Has ten years of experience in research and biotechnology start-up companies. CEO of Trinity Laboratories since 2009. In private practice since 1999. Assistant Professor at the University of Texas Health Science Center. DO from Texas College of Osteopathic Medicine, PhD in Biochemistry from UNT, MBA from UT Austin. Completed Orthopaedic Surgery residency at UTMB Gaveston.

  • Default avatar
    Chandra U. Singh

    Over thirty years in the pharmaceutical industry in drug development and rational drug design. Experience in biotechnology start-up companies being founder or co-founder of Trinity Laboratories, Azaya Therapeutics, Bionumerik and Immunopharmaceutics. Prior Assitant Professor at Scripps Clinical and Research Foundation. Received his PhD in Physical Chemistry from Madurai Kamaraj University, India and was a post-doctoral fellow at UCSF.


  • Default avatar
    Richard Howe, JD, CPA
    Default avatar
    Richard Howe, JD, CPA

Previous Investors

  • Default avatar
    Monterrey Bioscience S.A. de C.V.